Drug-induced glucose-6-phosphate dehydrogenase deficiency-related hemolysis risk assessment
暂无分享,去创建一个
[1] R. J. Dern,et al. The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine. , 1955, The Journal of laboratory and clinical medicine.
[2] Jack J. Pasternak. An Introduction to Human Molecular Genetics: Mechanisms of Inherited Diseases , 2000 .
[3] Angelo Balestrieri,et al. Treatment of chronic hepatitis C in patients with glucose-6-phosphate dehydrogenase deficiency: is ribavirin harmful? , 2006, Blood.
[4] Geoffrey I. Webb,et al. Efficient lazy elimination for averaged one-dependence estimators , 2006, ICML.
[5] Ali R Elyassi,et al. Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature. , 2009, Anesthesia progress.
[6] Geoffrey I. Webb,et al. Not So Naive Bayes: Aggregating One-Dependence Estimators , 2005, Machine Learning.
[7] M. Berkovitch,et al. Medications and Glucose-6-Phosphate Dehydrogenase Deficiency , 2010, Drug safety.
[8] Ernest Beutler,et al. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. , 2007, The American journal of tropical medicine and hygiene.